Viral and cellular requirements for the nuclear entry of retroviral preintegration nucleoprotein complexes

Viruses

Volumn 5, Issue 10, 2013, Pages 2483-2511

  Matreyek, Kenneth A ^a   Engelman, Alan ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Capsid; CPSF6; HIV; Lentivirus; Nuclear import; Nuclear pore complex; NUP153; NUP358; TNPO3

Indexed keywords

CYCLOPHILIN A; MESSENGER RNA; NUCLEOPROTEIN; PROTEIN NUP153; PROTEIN NUP358; PROTEIN TNPO3; UNCLASSIFIED DRUG; VIRUS PROTEIN;

BINDING SITE; CELL CYCLE ARREST; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; LENTIVIRINAE; MITOSIS; NONHUMAN; NUCLEAR IMPORT; NUCLEAR LOCALIZATION SIGNAL; PHENOTYPE; PROTEIN BINDING; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN LOCALIZATION; RETROVIRUS; REVIEW; RNA INTERFERENCE; VIRUS ENTRY; VIRUS NUCLEOCAPSID; VIRUS PARTICLE; VIRUS REPLICATION;

ACTIVE TRANSPORT, CELL NUCLEUS; DNA, VIRAL; HIV-1; HOST-PATHOGEN INTERACTIONS; HUMANS; MACROMOLECULAR SUBSTANCES; NUCLEAR PORE; NUCLEOPROTEINS; VIRAL PROTEINS; VIRUS INTEGRATION;

EID: 84885138769     PISSN: 19994915     EISSN: None     Source Type: Journal    
DOI: 10.3390/v5102483     Document Type: Review

References (189)

1. Roe, T.; Reynolds, T.C.; Yu, G.; Brown, P.O., Integration of Murine Leukemia Virus DNA Depends on Mitosis. EMBO J. 1993, 12, 2099-2108.
2. Gartner, S.; Markovits, P.; Markovitz, D.M.; Kaplan, M.H.; Gallo, R.C.; Popovic, M., The Role of Mononuclear Phagocytes in HTLV-III/LAV Infection. Science 1986, 233, 215-219.
3. Hoelz, A.; Debler, E.W.; Blobel, G., The Structure of the Nuclear Pore Complex. Annu. Rev. Biochem. 2011, 80, 613-643.
4. Rout, M.P.; Aitchison, J.D.; Suprapto, A.; Hjertaas, K.; Zhao, Y.; Chait, B.T., The Yeast Nuclear Pore Complex: Composition, Architecture, and Transport Mechanism. J. Cell Biol. 2000, 148, 635-651.
5. Cronshaw, J.M.; Krutchinsky, A.N.; Zhang, W.; Chait, B.T.; Matunis, M.J., Proteomic Analysis of the Mammalian Nuclear Pore Complex. J. Cell Biol. 2002, 158, 915-927.
6. Rout, M.P.; Blobel, G., Isolation of the Yeast Nuclear Pore Complex. J. Cell Biol. 1993, 123, 771-783.
7. Reichelt, R.; Holzenburg, A.; Buhle, E.L., Jr.; Jarnik, M.; Engel, A.; Aebi, U., Correlation between Structure and Mass Distribution of the Nuclear Pore Complex and of Distinct Pore Complex Components. J. Cell Biol. 1990, 110, 883-894.
8. Pante, N.; Kann, M., Nuclear Pore Complex Is Able to Transport Macromolecules with Diameters of About 39 nm. Mol. Biol. Cell 2002, 13, 425-434.
9. Conti, E.; Muller, C.W.; Stewart, M., Karyopherin Flexibility in Nucleocytoplasmic Transport. Curr. Opin. Struct. Biol. 2006, 16, 237-244.
10. Terry, L.J.; Wente, S.R., Flexible Gates: Dynamic Topologies and Functions for FG Nucleoporins in Nucleocytoplasmic Transport. Eukaryot. Cell 2009, 8, 1814-1827.
11. Nemergut, M.E.; Mizzen, C.A.; Stukenberg, T.; Allis, C.D.; Macara, I.G., Chromatin Docking and Exchange Activity Enhancement of RCC1 by Histones H2A and H2B. Science 2001, 292, 1540-1543.
12. Saitoh, H.; Pu, R.; Cavenagh, M.; Dasso, M., RanBP2 Associates with Ubc9p and a Modified Form of RanGAP1. Proc. Natl. Acad. Sci. U. S. A. 1997, 94, 3736-3741.
13. Radu, A.; Moore, M.S.; Blobel, G., The Peptide Repeat Domain of Nucleoporin NUP98 Functions as a Docking Site in Transport across the Nuclear Pore Complex. Cell 1995, 81, 215-222.
14. Bischoff, F.R.; Klebe, C.; Kretschmer, J.; Wittinghofer, A.; Ponstingl, H., RanGAP1 Induces GTPase Activity of Nuclear Ras-Related Ran. Proc. Natl. Acad. Sci. U. S. A. 1994, 91, 2587-2591.
15. Kehlenbach, R.H.; Dickmanns, A.; Kehlenbach, A.; Guan, T.; Gerace, L., A Role for RanBP1 in the Release of Crm1 from the Nuclear Pore Complex in a Terminal Step of Nuclear Export. J. Cell Biol. 1999, 145, 645-657.
16. Koyama, M.; Matsuura, Y., An Allosteric Mechanism to Displace Nuclear Export Cargo from Crm1 and RanGTP by RanBP1. EMBO J. 2010, 29, 2002-2013.
17. Brass, A.L.; Dykxhoorn, D.M.; Benita, Y.; Yan, N.; Engelman, A.; Xavier, R.J.; Lieberman, J.; Elledge, S.J., Identification of Host Proteins Required for HIV Infection through a Functional Genomic Screen. Science 2008, 319, 921-926.
18. Konig, R.; Zhou, Y.; Elleder, D.; Diamond, T.L.; Bonamy, G.M.; Irelan, J.T.; Chiang, C.Y.; Tu, B.P.; De Jesus, P.D.; Lilley, C.E., et al., Global Analysis of Host-Pathogen Interactions That Regulate Early-Stage HIV-1 Replication. Cell 2008, 135, 49-60.
19. Zhou, H.; Xu, M.; Huang, Q.; Gates, A.T.; Zhang, X.D.; Castle, J.C.; Stec, E.; Ferrer, M.; Strulovici, B.; Hazuda, D.J., et al., Genome-Scale RNAi Screen for Host Factors Required for HIV Replication. Cell Host Microbe 2008, 4, 495-504.
20. Yeung, M.L.; Houzet, L.; Yedavalli, V.S.; Jeang, K.T., A Genome-Wide Short Hairpin RNA Screening of Jurkat T-Cells for Human Proteins Contributing to Productive HIV-1 Replication. J. Biol. Chem. 2009, 284, 19463-19473.
21. Berthet-Colominas, C.; Monaco, S.; Novelli, A.; Sibai, G.; Mallet, F.; Cusack, S., Head-to-Tail Dimers and Interdomain Flexibility Revealed by the Crystal Structure of HIV-1 Capsid Protein (p24) Complexed with a Monoclonal Antibody Fab. EMBO J. 1999, 18, 1124-1136.
22. Ganser, B.K.; Li, S.; Klishko, V.Y.; Finch, J.T.; Sundquist, W.I., Assembly and Analysis of Conical Models for the HIV-1 Core. Science 1999, 283, 80-83.
23. Pornillos, O.; Ganser-Pornillos, B.K.; Kelly, B.N.; Hua, Y.; Whitby, F.G.; Stout, C.D.; Sundquist, W.I.; Hill, C.P.; Yeager, M., X-Ray Structures of the Hexameric Building Block of the HIV Capsid. Cell 2009, 137, 1282-1292.
24. Pornillos, O.; Ganser-Pornillos, B.K.; Yeager, M., Atomic-Level Modelling of the HIV Capsid. Nature 2011, 469, 424-427.
25. Zhao, G.; Perilla, J.R.; Yufenyuy, E.L.; Meng, X.; Chen, B.; Ning, J.; Ahn, J.; Gronenborn, A.M.; Schulten, K.; Aiken, C., et al., Mature HIV-1 Capsid Structure by Cryo-Electron Microscopy and All-Atom Molecular Dynamics. Nature 2013, 497, 643-646.
26. Fassati, A.; Goff, S.P., Characterization of Intracellular Reverse Transcription Complexes of Human Immunodeficiency Virus Type 1. J. Virol. 2001, 75, 3626-3635.
27. Hulme, A.E.; Perez, O.; Hope, T.J., Complementary Assays Reveal a Relationship between HIV-1 Uncoating and Reverse Transcription. Proc. Natl. Acad. Sci. U. S. A. 2011, 108, 9975-9980.
28. Arfi, V.; Lienard, J.; Nguyen, X.N.; Berger, G.; Rigal, D.; Darlix, J.L.; Cimarelli, A., Characterization of the Behavior of Functional Viral Genomes During the Early Steps of Human Immunodeficiency Virus Type 1 Infection. J. Virol. 2009, 83, 7524-7535.
29. Yu, Z.; Dobro, M.J.; Woodward, C.L.; Levandovsky, A.; Danielson, C.M.; Sandrin, V.; Shi, J.; Aiken, C.; Zandi, R.; Hope, T.J., et al., Unclosed HIV-1 Capsids Suggest a Curled Sheet Model of Assembly. J. Mol. Biol. 2013, 425, 112-123.
30. Pereira, C.F.; Rossy, J.; Owen, D.M.; Mak, J.; Gaus, K., HIV Taken by Storm: Super-Resolution Fluorescence Microscopy of a Viral Infection. Virol. J. 2012, 9, 84.
31. Lelek, M.; Di Nunzio, F.; Henriques, R.; Charneau, P.; Arhel, N.; Zimmer, C., Superresolution Imaging of HIV in Infected Cells with FlAsH-PALM. Proc. Natl. Acad. Sci. U. S. A. 2012, 109, 8564-8569.
32. McDonald, D.; Vodicka, M.A.; Lucero, G.; Svitkina, T.M.; Borisy, G.G.; Emerman, M.; Hope, T.J., Visualization of the Intracellular Behavior of HIV in Living Cells. J. Cell Biol. 2002, 159, 441-452.
33. Zack, J.A.; Arrigo, S.J.; Weitsman, S.R.; Go, A.S.; Haislip, A.; Chen, I.S., HIV-1 Entry into Quiescent Primary Lymphocytes: Molecular Analysis Reveals a Labile, Latent Viral Structure. Cell 1990, 61, 213-222.
34. Butler, S.L.; Hansen, M.S.; Bushman, F.D., A Quantitative Assay for HIV DNA Integration In Vivo. Nat. Med. 2001, 7, 631-634.
35. Sherman, P.A.; Fyfe, J.A., Human Immunodeficiency Virus Integration Protein Expressed in Escherichia Coli Possesses Selective DNA Cleaving Activity. Proc. Natl. Acad. Sci. U. S. A. 1990, 87, 5119-5123.
36. Bushman, F.D.; Craigie, R., Activities of Human Immunodeficiency Virus (HIV) Integration Protein In Vitro: Specific Cleavage and Integration of HIV DNA. Proc. Natl. Acad. Sci. U. S. A. 1991, 88, 1339-1343.
37. Engelman, A.; Mizuuchi, K.; Craigie, R., HIV-1 DNA Integration: Mechanism of Viral DNA Cleavage and DNA Strand Transfer. Cell 1991, 67, 1211-1221.
38. Miller, M.D.; Farnet, C.M.; Bushman, F.D., Human Immunodeficiency Virus Type 1 Preintegration Complexes: Studies of Organization and Composition. J. Virol. 1997, 71, 5382-5390.
39. Thomas, J.A.; Ott, D.E.; Gorelick, R.J., Efficiency of Human Immunodeficiency Virus Type 1 Postentry Infection Processes: Evidence against Disproportionate Numbers of Defective Virions. J. Virol. 2007, 81, 4367-4370.
40. Iordanskiy, S.; Berro, R.; Altieri, M.; Kashanchi, F.; Bukrinsky, M., Intracytoplasmic Maturation of the Human Immunodeficiency Virus Type 1 Reverse Transcription Complexes Determines Their Capacity to Integrate into Chromatin. Retrovirology 2006, 3, 4.
41. Yamashita, M.; Perez, O.; Hope, T.J.; Emerman, M., Evidence for Direct Involvement of the Capsid Protein in HIV Infection of Nondividing Cells. PLoS Pathog. 2007, 3, 1502-1510.
42. Thomas, J.A.; Gagliardi, T.D.; Alvord, W.G.; Lubomirski, M.; Bosche, W.J.; Gorelick, R.J., Human Immunodeficiency Virus Type 1 Nucleocapsid Zinc-Finger Mutations Cause Defects in Reverse Transcription and Integration. Virology 2006, 353, 41-51.
43. Kilzer, J.M.; Stracker, T.; Beitzel, B.; Meek, K.; Weitzman, M.; Bushman, F.D., Roles of Host Cell Factors in Circularization of Retroviral DNA. Virology 2003, 314, 460-467.
44. Miller, M.D.; Wang, B.; Bushman, F.D., Human Immunodeficiency Virus Type 1 Preintegration Complexes Containing Discontinuous Plus Strands Are Competent to Integrate In Vitro. J. Virol. 1995, 69, 3938-3944.
45. Munir, S.; Thierry, S.; Subra, F.; Deprez, E.; Delelis, O., Quantitative Analysis of the Time-Course of Viral DNA Forms During the HIV-1 Life Cycle. Retrovirology 2013, 10, 87.
46. Li, L.; Olvera, J.M.; Yoder, K.E.; Mitchell, R.S.; Butler, S.L.; Lieber, M.; Martin, S.L.; Bushman, F.D., Role of the Non-Homologous DNA End Joining Pathway in the Early Steps of Retroviral Infection. EMBO J. 2001, 20, 3272-3281.
47. Li, Y.; Kappes, J.C.; Conway, J.A.; Price, R.W.; Shaw, G.M.; Hahn, B.H., Molecular Characterization of Human Immunodeficiency Virus Type 1 Cloned Directly from Uncultured Human Brain Tissue: Identification of Replication-Competent and-Defective Viral Genomes. J. Virol. 1991, 65, 3973-3985.
48. Farnet, C.M.; Haseltine, W.A., Circularization of Human Immunodeficiency Virus Type 1 DNA In Vitro. J. Virol. 1991, 65, 6942-6952.
49. Yan, N.; Cherepanov, P.; Daigle, J.E.; Engelman, A.; Lieberman, J., The SET Complex Acts as a Barrier to Autointegration of HIV-1. PLoS Pathog. 2009, 5, e1000327.
50. De Iaco, A.; Santoni, F.; Vannier, A.; Guipponi, M.; Antonarakis, S.; Luban, J., TNPO3 Protects HIV-1 Replication from CPSF6-Mediated Capsid Stabilization in the Host Cell Cytoplasm. Retrovirology 2013, 10, 20.
51. Brussel, A.; Sonigo, P., Analysis of Early Human Immunodeficiency Virus Type 1 DNA Synthesis by Use of a New Sensitive Assay for Quantifying Integrated Provirus. J. Virol. 2003, 77, 10119-10124.
52. Schroder, A.R.; Shinn, P.; Chen, H.; Berry, C.; Ecker, J.R.; Bushman, F., HIV-1 Integration in the Human Genome Favors Active Genes and Local Hotspots. Cell 2002, 110, 521-529.
53. Mitchell, R.S.; Beitzel, B.F.; Schroder, A.R.; Shinn, P.; Chen, H.; Berry, C.C.; Ecker, J.R.; Bushman, F.D., Retroviral DNA Integration: ASLV, HIV, and MLV Show Distinct Target Site Preferences. PLoS Biol. 2004, 2, E234.
54. Christ, F.; Thys, W.; De Rijck, J.; Gijsbers, R.; Albanese, A.; Arosio, D.; Emiliani, S.; Rain, J.C.; Benarous, R.; Cereseto, A., et al., Transportin-SR2 Imports HIV into the Nucleus. Curr. Biol. 2008, 18, 1192-1202.
55. Di Primio, C.; Quercioli, V.; Allouch, A.; Gijsbers, R.; Christ, F.; Debyser, Z.; Arosio, D.; Cereseto, A., Single-Cell Imaging of HIV-1 Provirus (SCIP). Proc. Natl. Acad. Sci. U. S. A. 2013, 110, 5636-5641.
56. Li, M.; Mizuuchi, M.; Burke, T.R., Jr.; Craigie, R., Retroviral DNA Integration: Reaction Pathway and Critical Intermediates. EMBO J. 2006, 25, 1295-1304.
57. Hare, S.; Gupta, S.S.; Valkov, E.; Engelman, A.; Cherepanov, P., Retroviral Intasome Assembly and Inhibition of DNA Strand Transfer. Nature 2010, 464, 232-236.
58. Bukrinsky, M.I.; Sharova, N.; McDonald, T.L.; Pushkarskaya, T.; Tarpley, W.G.; Stevenson, M., Association of Integrase, Matrix, and Reverse Transcriptase Antigens of Human Immunodeficiency Virus Type 1 with Viral Nucleic Acids Following Acute Infection. Proc. Natl. Acad. Sci. U. S. A. 1993, 90, 6125-6129.
59. Gallay, P.; Swingler, S.; Song, J.; Bushman, F.; Trono, D., HIV Nuclear Import Is Governed by the Phosphotyrosine-Mediated Binding of Matrix to the Core Domain of Integrase. Cell 1995, 83, 569-576.
60. Gallay, P.; Hope, T.; Chin, D.; Trono, D., HIV-1 Infection of Nondividing Cells through the Recognition of Integrase by the Importin/Karyopherin Pathway. Proc. Natl. Acad. Sci. U. S. A. 1997, 94, 9825-9830.
61. Heinzinger, N.K.; Bukinsky, M.I.; Haggerty, S.A.; Ragland, A.M.; Kewalramani, V.; Lee, M.A.; Gendelman, H.E.; Ratner, L.; Stevenson, M.; Emerman, M., The Vpr Protein of Human Immunodeficiency Virus Type 1 Influences Nuclear Localization of Viral Nucleic Acids in Nondividing Host Cells. Proc. Natl. Acad. Sci. U. S. A. 1994, 91, 7311-7315.
62. Karageorgos, L.; Li, P.; Burrell, C., Characterization of HIV Replication Complexes Early after Cell-to-Cell Infection. AIDS Res. Hum. Retrov. 1993, 9, 817-823.
63. Arhel, N.J.; Souquere-Besse, S.; Munier, S.; Souque, P.; Guadagnini, S.; Rutherford, S.; Prevost, M.C.; Allen, T.D.; Charneau, P., HIV-1 DNA Flap Formation Promotes Uncoating of the Pre-Integration Complex at the Nuclear Pore. EMBO J. 2007, 26, 3025-3037.
64. Meehan, A.M.; Saenz, D.T.; Morrison, J.; Hu, C.; Peretz, M.; Poeschla, E.M., LEDGF Dominant Interference Proteins Demonstrate Prenuclear Exposure of HIV-1 Integrase and Synergize with LEDGF Depletion to Destroy Viral Infectivity. J. Virol. 2011, 85, 3570-3583.
65. Zhou, L.; Sokolskaja, E.; Jolly, C.; James, W.; Cowley, S.A.; Fassati, A., Transportin 3 Promotes a Nuclear Maturation Step Required for Efficient HIV-1 Integration. PLoS Pathog. 2011, 7, e1002194.
66. Di Nunzio, F.; Danckaert, A.; Fricke, T.; Perez, P.; Fernandez, J.; Perret, E.; Roux, P.; Shorte, S.; Charneau, P.; Diaz-Griffero, F., et al., Human Nucleoporins Promote HIV-1 Docking at the Nuclear Pore, Nuclear Import and Integration. PLoS One 2012, 7, e46037.
67. Bukrinsky, M.I.; Haggerty, S.; Dempsey, M.P.; Sharova, N.; Adzhubel, A.; Spitz, L.; Lewis, P.; Goldfarb, D.; Emerman, M.; Stevenson, M., A Nuclear Localization Signal within HIV-1 Matrix Protein That Governs Infection of Non-Dividing Cells. Nature 1993, 365, 666-669.
68. Haffar, O.K.; Popov, S.; Dubrovsky, L.; Agostini, I.; Tang, H.; Pushkarsky, T.; Nadler, S.G.; Bukrinsky, M., Two Nuclear Localization Signals in the HIV-1 Matrix Protein Regulate Nuclear Import of the HIV-1 Pre-Integration Complex. J. Mol. Biol. 2000, 299, 359-368.
69. Bouyac-Bertoia, M.; Dvorin, J.D.; Fouchier, R.A.; Jenkins, Y.; Meyer, B.E.; Wu, L.I.; Emerman, M.; Malim, M.H., HIV-1 Infection Requires a Functional Integrase NLS. Mol. Cell. 2001, 7, 1025-1035.
70. Fouchier, R.A.; Meyer, B.E.; Simon, J.H.; Fischer, U.; Albright, A.V.; Gonzalez-Scarano, F.; Malim, M.H., Interaction of the Human Immunodeficiency Virus Type 1 Vpr Protein with the Nuclear Pore Complex. J. Virol. 1998, 72, 6004-6013.
71. Vodicka, M.A.; Koepp, D.M.; Silver, P.A.; Emerman, M., HIV-1 Vpr Interacts with the Nuclear Transport Pathway to Promote Macrophage Infection. Genes Dev. 1998, 12, 175-185.
72. Popov, S.; Rexach, M.; Ratner, L.; Blobel, G.; Bukrinsky, M., Viral Protein R Regulates Docking of the HIV-1 Preintegration Complex to the Nuclear Pore Complex. J. Biol. Chem. 1998, 273, 13347-13352.
73. Popov, S.; Rexach, M.; Zybarth, G.; Reiling, N.; Lee, M.A.; Ratner, L.; Lane, C.M.; Moore, M.S.; Blobel, G.; Bukrinsky, M., Viral Protein R Regulates Nuclear Import of the HIV-1 Pre-Integration Complex. EMBO J. 1998, 17, 909-917.
74. Jenkins, Y.; McEntee, M.; Weis, K.; Greene, W.C., Characterization of HIV-1 Vpr Nuclear Import: Analysis of Signals and Pathways. J. Cell Biol. 1998, 143, 875-885.
75. Ao, Z.; Danappa Jayappa, K.; Wang, B.; Zheng, Y.; Kung, S.; Rassart, E.; Depping, R.; Kohler, M.; Cohen, E.A.; Yao, X., Importin Alpha3 Interacts with HIV-1 Integrase and Contributes to HIV-1 Nuclear Import and Replication. J. Virol. 2010, 84, 8650-8663.
76. Fassati, A.; Gorlich, D.; Harrison, I.; Zaytseva, L.; Mingot, J.M., Nuclear Import of HIV-1 Intracellular Reverse Transcription Complexes Is Mediated by Importin 7. EMBO J. 2003, 22, 3675-3685.
77. Ao, Z.; Huang, G.; Yao, H.; Xu, Z.; Labine, M.; Cochrane, A.W.; Yao, X., Interaction of Human Immunodeficiency Virus Type 1 Integrase with Cellular Nuclear Import Receptor Importin 7 and Its Impact on Viral Replication. J. Biol. Chem. 2007, 282, 13456-13467.
78. Larue, R.; Gupta, K.; Wuensch, C.; Shkriabai, N.; Kessl, J.J.; Danhart, E.; Feng, L.; Taltynov, O.; Christ, F.; Van Duyne, G.D., et al., Interaction of the HIV-1 Intasome with Transportin 3 Protein (TNPO3 or TRN-SR2). J. Biol. Chem. 2012, 287, 34044-34058.
79. Zielske, S.P.; Stevenson, M., Importin 7 May Be Dispensable for Human Immunodeficiency Virus Type 1 and Simian Immunodeficiency Virus Infection of Primary Macrophages. J. Virol. 2005, 79, 11541-11546.
80. Krishnan, L.; Matreyek, K.A.; Oztop, I.; Lee, K.; Tipper, C.H.; Li, X.; Dar, M.J.; Kewalramani, V.N.; Engelman, A., The Requirement for Cellular Transportin 3 (TNPO3 or TRN-SR2) During Infection Maps to Human Immunodeficiency Virus Type 1 Capsid and Not Integrase. J. Virol. 2010, 84, 397-406.
81. Cribier, A.; Segeral, E.; Delelis, O.; Parissi, V.; Simon, A.; Ruff, M.; Benarous, R.; Emiliani, S., Mutations Affecting Interaction of Integrase with TNPO3 Do Not Prevent HIV-1 cDNA Nuclear Import. Retrovirology 2011, 8, 104.
82. Woodward, C.L.; Prakobwanakit, S.; Mosessian, S.; Chow, S.A., Integrase Interacts with Nucleoporin NUP153 to Mediate the Nuclear Import of Human Immunodeficiency Virus Type 1. J. Virol. 2009, 83, 6522-6533.
83. Le Rouzic, E.; Mousnier, A.; Rustum, C.; Stutz, F.; Hallberg, E.; Dargemont, C.; Benichou, S., Docking of HIV-1 Vpr to the Nuclear Envelope Is Mediated by the Interaction with the Nucleoporin HCG1. J. Biol. Chem. 2002, 277, 45091-45098.
84. Zennou, V.; Petit, C.; Guetard, D.; Nerhbass, U.; Montagnier, L.; Charneau, P., HIV-1 Genome Nuclear Import Is Mediated by a Central DNA Flap. Cell 2000, 101, 173-185.
85. Follenzi, A.; Ailles, L.E.; Bakovic, S.; Geuna, M.; Naldini, L., Gene Transfer by Lentiviral Vectors Is Limited by Nuclear Translocation and Rescued by HIV-1 Pol Sequences. Nat. Genet. 2000, 25, 217-222.
86. Limon, A.; Nakajima, N.; Lu, R.; Ghory, H.Z.; Engelman, A., Wild-Type Levels of Nuclear Localization and Human Immunodeficiency Virus Type 1 Replication in the Absence of the Central DNA Flap. J. Virol. 2002, 76, 12078-12086.
87. Dvorin, J.D.; Bell, P.; Maul, G.G.; Yamashita, M.; Emerman, M.; Malim, M.H., Reassessment of the Roles of Integrase and the Central DNA Flap in Human Immunodeficiency Virus Type 1 Nuclear Import. J. Virol. 2002, 76, 12087-12096.
88. Marsden, M.D.; Zack, J.A., Human Immunodeficiency Virus Bearing a Disrupted Central DNA Flap Is Pathogenic In Vivo. J. Virol. 2007, 81, 6146-6150.
89. De Rijck, J.; Debyser, Z., The Central DNA Flap of the Human Immunodeficiency Virus Type 1 Is Important for Viral Replication. Biochem. Biophys. Res. Commun. 2006, 349, 1100-1110.
90. Riviere, L.; Darlix, J.L.; Cimarelli, A., Analysis of the Viral Elements Required in the Nuclear Import of HIV-1 DNA. J. Virol. 2010, 84, 729-739.
91. Ao, Z.; Yao, X.; Cohen, E.A., Assessment of the Role of the Central DNA Flap in Human Immunodeficiency Virus Type 1 Replication by Using a Single-Cycle Replication System. J. Virol. 2004, 78, 3170-3177.
92. Skasko, M.; Kim, B., Compensatory Role of Human Immunodeficiency Virus Central Polypurine Tract Sequence in Kinetically Disrupted Reverse Transcription. J. Virol. 2008, 82, 7716-7720.
93. Hu, C.; Saenz, D.T.; Fadel, H.J.; Walker, W.; Peretz, M.; Poeschla, E.M., The HIV-1 Central Polypurine Tract Functions as a Second Line of Defense against APOBEC3G/F. J. Virol. 2010, 84, 11981-11993.
94. Wurtzer, S.; Goubard, A.; Mammano, F.; Saragosti, S.; Lecossier, D.; Hance, A.J.; Clavel, F., Functional Central Polypurine Tract Provides Downstream Protection of the Human Immunodeficiency Virus Type 1 Genome from Editing by APOBEC3G and APOBEC3B. J. Virol. 2006, 80, 3679-3683.
95. Suspene, R.; Rusniok, C.; Vartanian, J.P.; Wain-Hobson, S., Twin Gradients in APOBEC3 Edited HIV-1 DNA Reflect the Dynamics of Lentiviral Replication. Nucleic Acids Res. 2006, 34, 4677-4684.
96. Poeschla, E., The Importance of Becoming Double-Stranded: Innate Immunity and the Kinetic Model of HIV-1 Central Plus Strand Synthesis. Virology 2013, 441, 1-11.
97. Limon, A.; Devroe, E.; Lu, R.; Ghory, H.Z.; Silver, P.A.; Engelman, A., Nuclear Localization of Human Immunodeficiency Virus Type 1 Preintegration Complexes (PICS): V165A and R166A Are Pleiotropic Integrase Mutants Primarily Defective for Integration, Not PIC Nuclear Import. J. Virol. 2002, 76, 10598-10607.
98. Fouchier, R.A.; Meyer, B.E.; Simon, J.H.; Fischer, U.; Malim, M.H., HIV-1 Infection of Non-Dividing Cells: Evidence That the Amino-Terminal Basic Region of the Viral Matrix Protein Is Important for Gag Processing but Not for Post-Entry Nuclear Import. EMBO J. 1997, 16, 4531-4539.
99. Freed, E.O.; Englund, G.; Martin, M.A., Role of the Basic Domain of Human Immunodeficiency Virus Type 1 Matrix in Macrophage Infection. J. Virol. 1995, 69, 3949-3954.
100. Katz, R.A.; Greger, J.G.; Boimel, P.; Skalka, A.M., Human Immunodeficiency Virus Type 1 DNA Nuclear Import and Integration Are Mitosis Independent in Cycling Cells. J. Virol. 2003, 77, 13412-13417.
101. Yamashita, M.; Emerman, M., Capsid Is a Dominant Determinant of Retrovirus Infectivity in Nondividing Cells. J. Virol. 2004, 78, 5670-5678.
102. Qi, M.; Yang, R.; Aiken, C., Cyclophilin A-Dependent Restriction of Human Immunodeficiency Virus Type 1 Capsid Mutants for Infection of Nondividing Cells. J. Virol. 2008, 82, 12001-12008.
103. Ylinen, L.M.; Schaller, T.; Price, A.; Fletcher, A.J.; Noursadeghi, M.; James, L.C.; Towers, G.J., Cyclophilin A Levels Dictate Infection Efficiency of Human Immunodeficiency Virus Type 1 Capsid Escape Mutants A92E and G94D. J. Virol. 2009, 83, 2044-2047.
104. Dismuke, D.J.; Aiken, C., Evidence for a Functional Link between Uncoating of the Human Immunodeficiency Virus Type 1 Core and Nuclear Import of the Viral Preintegration Complex. J. Virol. 2006, 80, 3712-3720.
105. Forshey, B.M.; von Schwedler, U.; Sundquist, W.I.; Aiken, C., Formation of a Human Immunodeficiency Virus Type 1 Core of Optimal Stability Is Crucial for Viral Replication. J. Virol. 2002, 76, 5667-5677.
106. Stremlau, M.; Owens, C.M.; Perron, M.J.; Kiessling, M.; Autissier, P.; Sodroski, J., The Cytoplasmic Body Component Trim5alpha Restricts HIV-1 Infection in Old World Monkeys. Nature 2004, 427, 848-853.
107. Stremlau, M.; Perron, M.; Lee, M.; Li, Y.; Song, B.; Javanbakht, H.; Diaz-Griffero, F.; Anderson, D.J.; Sundquist, W.I.; Sodroski, J., Specific Recognition and Accelerated Uncoating of Retroviral Capsids by the Trim5alpha Restriction Factor. Proc. Natl. Acad. Sci. U. S. A. 2006, 103, 5514-5519.
108. Wu, X.; Anderson, J.L.; Campbell, E.M.; Joseph, A.M.; Hope, T.J., Proteasome Inhibitors Uncouple Rhesus Trim5alpha Restriction of HIV-1 Reverse Transcription and Infection. Proc. Natl. Acad. Sci. U. S. A. 2006, 103, 7465-7470.
109. Kutluay, S.B.; Perez-Caballero, D.; Bieniasz, P.D., Fates of Retroviral Core Components During Unrestricted and Trim5-Restricted Infection. PLoS Pathog. 2013, 9, e1003214.
110. Anderson, J.L.; Campbell, E.M.; Wu, X.; Vandegraaff, N.; Engelman, A.; Hope, T.J., Proteasome Inhibition Reveals That a Functional Preintegration Complex Intermediate Can Be Generated During Restriction by Diverse Trim5 Proteins. J. Virol. 2006, 80, 9754-9760.
111. Danielson, C.M.; Cianci, G.C.; Hope, T.J., Recruitment and Dynamics of Proteasome Association with rhTrim5alpha Cytoplasmic Complexes During HIV-1 Infection. Traffic 2012, 13, 1206-1217.
112. Yap, M.W.; Dodding, M.P.; Stoye, J.P., Trim-Cyclophilin A Fusion Proteins Can Restrict Human Immunodeficiency Virus Type 1 Infection at Two Distinct Phases in the Viral Life Cycle. J. Virol. 2006, 80, 4061-4067.
113. Hori, T.; Takeuchi, H.; Saito, H.; Sakuma, R.; Inagaki, Y.; Yamaoka, S., A Carboxy-Terminally Truncated Human CPSF6 Lacking Residues Encoded by Exon 6 Inhibits HIV-1 cDNA Synthesis and Promotes Capsid Disassembly. J. Virol. 2013.
114. Lee, K.; Ambrose, Z.; Martin, T.D.; Oztop, I.; Mulky, A.; Julias, J.G.; Vandegraaff, N.; Baumann, J.G.; Wang, R.; Yuen, W., et al., Flexible Use of Nuclear Import Pathways by HIV-1. Cell Host Microbe 2010, 7, 221-233.
115. Lee, K.; Mulky, A.; Yuen, W.; Martin, T.D.; Meyerson, N.R.; Choi, L.; Yu, H.; Sawyer, S.L.; Kewalramani, V.N., HIV-1 Capsid-Targeting Domain of Cleavage and Polyadenylation Specificity Factor 6. J. Virol. 2012, 86, 3851-3860.
116. Goujon, C.; Moncorge, O.; Bauby, H.; Doyle, T.; Ward, C.C.; Schaller, T.; Hue, S.; Barclay, W.; Schulz, R.; Malim, M.H., Human MX2 Is an Interferon-Induced Post-Entry Inhibitor of HIV-1 Infection. Nature 2013, DOI: 10.1038/nature12542.
117. Liu, Z.; Pan, Q.; Ding, S.; Qian, J.; Xu, F.; Zhou, J.; Cen, S.; Guo, F.; Liang, C., The Interferon-Inducible MXB Protein Inhibits HIV-1 Infection. Cell Host Microbe 2013, DOI: 10.1016/j.chom.2013.1008.1015.
118. Blair, W.S.; Pickford, C.; Irving, S.L.; Brown, D.G.; Anderson, M.; Bazin, R.; Cao, J.; Ciaramella, G.; Isaacson, J.; Jackson, L., et al., HIV Capsid Is a Tractable Target for Small Molecule Therapeutic Intervention. PLoS Pathog. 2010, 6, e1001220.
119. Shi, J.; Zhou, J.; Shah, V.B.; Aiken, C.; Whitby, K., Small-Molecule Inhibition of Human Immunodeficiency Virus Type 1 Infection by Virus Capsid Destabilization. J. Virol. 2011, 85, 542-549.
120. Lamorte, L.; Titolo, S.; Lemke, C.T.; Goudreau, N.; Mercier, J.F.; Wardrop, E.; Shah, V.B.; von Schwedler, U.K.; Langelier, C.; Banik, S.S., et al., Discovery of Novel Small Molecule HIV-1 Replication Inhibitors That Stabilize Capsid Complexes. Antimicrob. Agents Chemother. 2013, 57, 4622-4631.
121. Price, A.J.; Fletcher, A.J.; Schaller, T.; Elliott, T.; Lee, K.; KewalRamani, V.N.; Chin, J.W.; Towers, G.J.; James, L.C., CPSF6 Defines a Conserved Capsid Interface That Modulates HIV-1 Replication. PLoS Pathog. 2012, 8, e1002896.
122. Matreyek, K.A.; Yücel, S.S.; Li, X.; Engelman, A., Nucleoporin NUP153 Phenylalanine-Glycine Motifs Engage a Common Binding Pocket within the HIV-1 Capsid Protein to Mediate Lentiviral Infectivity. PLoS Pathog. 2013, In Press.
123. Vozzolo, L.; Loh, B.; Gane, P.J.; Tribak, M.; Zhou, L.; Anderson, I.; Nyakatura, E.; Jenner, R.G.; Selwood, D.; Fassati, A., Gyrase B Inhibitor Impairs HIV-1 Replication by Targeting HSP90 and the Capsid Protein. J. Biol. Chem. 2010, 285, 39314-39328.
124. Fassati, A.; Goff, S.P., Characterization of Intracellular Reverse Transcription Complexes of Moloney Murine Leukemia Virus. J. Virol. 1999, 73, 8919-8925.
125. Yuan, B.; Li, X.; Goff, S.P., Mutations Altering the Moloney Murine Leukemia Virus p12 Gag Protein Affect Virion Production and Early Events of the Virus Life Cycle. EMBO J. 1999, 18, 4700-4710.
126. Prizan-Ravid, A.; Elis, E.; Laham-Karam, N.; Selig, S.; Ehrlich, M.; Bacharach, E., The Gag Cleavage Product, p12, Is a Functional Constituent of the Murine Leukemia Virus Pre-Integration Complex. PLoS Pathog. 2010, 6, e1001183.
127. Schneider, W.M.; Brzezinski, J.D.; Aiyer, S.; Malani, N.; Gyuricza, M.; Bushman, F.D.; Roth, M.J., Viral DNA Tethering Domains Complement Replication-Defective Mutations in the p12 Protein of MuLV Gag. Proc. Natl. Acad. Sci. U. S. A. 2013, 110, 9487-9492.
128. Elis, E.; Ehrlich, M.; Prizan-Ravid, A.; Laham-Karam, N.; Bacharach, E., P12 Tethers the Murine Leukemia Virus Pre-Integration Complex to Mitotic Chromosomes. PLoS Pathog. 2012, 8, e1003103.
129. Best, S.; Le Tissier, P.; Towers, G.; Stoye, J.P., Positional Cloning of the Mouse Retrovirus Restriction Gene Fv1. Nature 1996, 382, 826-829.
130. Hopkins, N.; Schindler, J.; Hynes, R., Six-NB-Tropic Murine Leukemia Viruses Derived from a B-Tropic Virus of Balb/C Have Altered p30. J. Virol. 1977, 21, 309-318.
131. Rommelaere, J.; Donis-Keller, H.; Hopkins, N., RNA Sequencing Provides Evidence for Allelism of Determinants of the N-, B-or NB-Tropism of Murine Leukemia Viruses. Cell 1979, 16, 43-50.
132. Hilditch, L.; Matadeen, R.; Goldstone, D.C.; Rosenthal, P.B.; Taylor, I.A.; Stoye, J.P., Ordered Assembly of Murine Leukemia Virus Capsid Protein on Lipid Nanotubes Directs Specific Binding by the Restriction Factor, Fv1. Proc. Natl. Acad. Sci. U. S. A. 2011, 108, 5771-5776.
133. Pryciak, P.M.; Varmus, H.E., Fv-1 Restriction and Its Effects on Murine Leukemia Virus Integration In Vivo and In Vitro. J. Virol. 1992, 66, 5959-5966.
134. Yang, W.K.; Kiggans, J.O.; Yang, D.M.; Ou, C.Y.; Tennant, R.W.; Brown, A.; Bassin, R.H., Synthesis and Circularization of N-and B-Tropic Retroviral DNA Fv-1 Permissive and Restrictive Mouse Cells. Proc. Natl. Acad. Sci. U. S. A. 1980, 77, 2994-2998.
135. Jolicoeur, P.; Rassart, E., Effect of Fv-1 Gene Product on Synthesis of Linear and Supercoiled Viral DNA in Cells Infected with Murine Leukemia Virus. J. Virol. 1980, 33, 183-195.
136. Schaller, T.; Ylinen, L.M.; Webb, B.L.; Singh, S.; Towers, G.J., Fusion of Cyclophilin A to Fv1 Enables Cyclosporine-Sensitive Restriction of Human and Feline Immunodeficiency Viruses. J. Virol. 2007, 81, 10055-10063.
137. Bushman, F.D.; Malani, N.; Fernandes, J.; D'Orso, I.; Cagney, G.; Diamond, T.L.; Zhou, H.; Hazuda, D.J.; Espeseth, A.S.; Konig, R., et al., Host Cell Factors in HIV Replication: Meta-Analysis of Genome-Wide Studies. PLoS Pathog. 2009, 5, e1000437.
138. Zhang, R.; Mehla, R.; Chauhan, A., Perturbation of Host Nuclear Membrane Component RanBP2 Impairs the Nuclear Import of Human Immunodeficiency Virus 1 Preintegration Complex (DNA). PLoS One 2010, 5, e15620.
139. Schaller, T.; Ocwieja, K.E.; Rasaiyaah, J.; Price, A.J.; Brady, T.L.; Roth, S.L.; Hue, S.; Fletcher, A.J.; Lee, K.; KewalRamani, V.N., et al., HIV-1 Capsid-Cyclophilin Interactions Determine Nuclear Import Pathway, Integration Targeting and Replication Efficiency. PLoS Pathog. 2011, 7, e1002439.
140. Matreyek, K.A.; Engelman, A., The Requirement for Nucleoporin NUP153 During Human Immunodeficiency Virus Type 1 Infection Is Determined by the Viral Capsid. J. Virol. 2011, 85, 7818-7827.
141. Logue, E.C.; Taylor, K.T.; Goff, P.H.; Landau, N.R., The Cargo-Binding Domain of Transportin 3 Is Required for Lentivirus Nuclear Import. J. Virol. 2011, 85, 12950-12961.
142. De Iaco, A.; Luban, J., Inhibition of HIV-1 Infection by TNPO3 Depletion Is Determined by Capsid and Detectable after Viral cDNA Enters the Nucleus. Retrovirology 2011, 8, 98.
143. Valle-Casuso, J.C.; Di Nunzio, F.; Yang, Y.; Reszka, N.; Lienlaf, M.; Arhel, N.; Perez, P.; Brass, A.L.; Diaz-Griffero, F., TNPO3 Is Required for HIV-1 Replication after Nuclear Import but Prior to Integration and Binds the HIV-1 Core. J. Virol. 2012, 86, 5931-5936.
144. Hutten, S.; Kehlenbach, R.H., NUP214 Is Required for Crm1-Dependent Nuclear Protein Export In Vivo. Mol. Cell. Biol. 2006, 26, 6772-6785.
145. Walther, T.C.; Alves, A.; Pickersgill, H.; Loiodice, I.; Hetzer, M.; Galy, V.; Hulsmann, B.B.; Kocher, T.; Wilm, M.; Allen, T., et al., The Conserved NUP107-160 Complex Is Critical for Nuclear Pore Complex Assembly. Cell 2003, 113, 195-206.
146. Hase, M.E.; Cordes, V.C., Direct Interaction with NUP153 Mediates Binding of Tpr to the Periphery of the Nuclear Pore Complex. Mol. Biol. Cell 2003, 14, 1923-1940.
147. Arnaoutov, A.; Azuma, Y.; Ribbeck, K.; Joseph, J.; Boyarchuk, Y.; Karpova, T.; McNally, J.; Dasso, M., Crm1 Is a Mitotic Effector of Ran-GTP in Somatic Cells. Nat Cell Biol 2005, 7, 626-632.
148. Dawlaty, M.M.; Malureanu, L.; Jeganathan, K.B.; Kao, E.; Sustmann, C.; Tahk, S.; Shuai, K.; Grosschedl, R.; van Deursen, J.M., Resolution of Sister Centromeres Requires RanBP2-Mediated Sumoylation of Topoisomerase IIalpha. Cell 2008, 133, 103-115.
149. Zuccolo, M.; Alves, A.; Galy, V.; Bolhy, S.; Formstecher, E.; Racine, V.; Sibarita, J.B.; Fukagawa, T.; Shiekhattar, R.; Yen, T., et al., The Human NUP107-160 Nuclear Pore Subcomplex Contributes to Proper Kinetochore Functions. EMBO J. 2007, 26, 1853-1864.
150. Thys, W.; De Houwer, S.; Demeulemeester, J.; Taltynov, O.; Vancraenenbroeck, R.; Gerard, M.; De Rijck, J.; Gijsbers, R.; Christ, F.; Debyser, Z., Interplay between HIV Entry and Transportin-SR2 Dependency. Retrovirology 2011, 8, 7.
151. Fricke, T.; Valle-Casuso, J.C.; White, T.E.; Brandariz-Nunez, A.; Bosche, W.J.; Reszka, N.; Gorelick, R.; Diaz-Griffero, F., The Ability of TNPO3-Depleted Cells to Inhibit HIV-1 Infection Requires CPSF6. Retrovirology 2013, 10, 46.
152. De Houwer, S.; Demeulemeester, J.; Thys, W.; Taltynov, O.; Zmajkovicova, K.; Christ, F.; Debyser, Z., Identification of Residues in the C-Terminal Domain of HIV-1 Integrase That Mediate Binding to the Transportin-SR2 Protein. J. Biol. Chem. 2012, 287, 34059-34068.
153. Taltynov, O.; Demeulemeester, J.; Christ, F.; De Houwer, S.; Tsirkone, V.G.; Gerard, M.; Weeks, S.D.; Strelkov, S.V.; Debyser, Z., Interaction of Transportin-SR2 with Ras-Related Nuclear Protein (Ran) GTPase. J. Biol. Chem. 2013, 288, 25603-25613.
154. Shah, V.B.; Shi, J.; Hout, D.R.; Oztop, I.; Krishnan, L.; Ahn, J.; Shotwell, M.S.; Engelman, A.; Aiken, C., The Host Proteins Transportin SR2/TNPO3 and Cyclophilin A Exert Opposing Effects on HIV-1 Uncoating. J. Virol. 2013, 87, 422-432.
155. Kataoka, N.; Bachorik, J.L.; Dreyfuss, G., Transportin-SR, a Nuclear Import Receptor for SR Proteins. J. Cell Biol. 1999, 145, 1145-1152.
156. Sukegawa, J.; Blobel, G., A Nuclear Pore Complex Protein That Contains Zinc Finger Motifs, Binds DNA, and Faces the Nucleoplasm. Cell 1993, 72, 29-38.
157. Enarson, P.; Enarson, M.; Bastos, R.; Burke, B., Amino-Terminal Sequences That Direct Nucleoporin NUP153 to the Inner Surface of the Nuclear Envelope. Chromosoma 1998, 107, 228-236.
158. Lim, R.Y.; Huang, N.P.; Koser, J.; Deng, J.; Lau, K.H.; Schwarz-Herion, K.; Fahrenkrog, B.; Aebi, U., Flexible Phenylalanine-Glycine Nucleoporins as Entropic Barriers to Nucleocytoplasmic Transport. Proc. Natl. Acad. Sci. U. S. A. 2006, 103, 9512-9517.
159. Cardarelli, F.; Lanzano, L.; Gratton, E., Capturing Directed Molecular Motion in the Nuclear Pore Complex of Live Cells. Proc. Natl. Acad. Sci. U. S. A. 2012, 109, 9863-9868.
160. Fahrenkrog, B.; Maco, B.; Fager, A.M.; Koser, J.; Sauder, U.; Ullman, K.S.; Aebi, U., Domain-Specific Antibodies Reveal Multiple-Site Topology of NUP153 within the Nuclear Pore Complex. J. Struct. Biol. 2002, 140, 254-267.
161. Paulillo, S.M.; Phillips, E.M.; Koser, J.; Sauder, U.; Ullman, K.S.; Powers, M.A.; Fahrenkrog, B., Nucleoporin Domain Topology Is Linked to the Transport Status of the Nuclear Pore Complex. J. Mol. Biol. 2005, 351, 784-798.
162. Di Nunzio, F.; Fricke, T.; Miccio, A.; Valle-Casuso, J.C.; Perez, P.; Souque, P.; Rizzi, E.; Severgnini, M.; Mavilio, F.; Charneau, P., et al., NUP153 and NUP98 Bind the HIV-1 Core and Contribute to the Early Steps of HIV-1 Replication. Virology 2013, 440, 8-18.
163. Yokoyama, N.; Hayashi, N.; Seki, T.; Pante, N.; Ohba, T.; Nishii, K.; Kuma, K.; Hayashida, T.; Miyata, T.; Aebi, U., et al., A Giant Nucleopore Protein That Binds Ran/TC4. Nature 1995, 376, 184-188.
164. Wu, J.; Matunis, M.J.; Kraemer, D.; Blobel, G.; Coutavas, E., Nup358, a Cytoplasmically Exposed Nucleoporin with Peptide Repeats, Ran-GTP Binding Sites, Zinc Fingers, a Cyclophilin A Homologous Domain, and a Leucine-Rich Region. J. Biol. Chem. 1995, 270, 14209-14213.
165. Wilken, N.; Senecal, J.L.; Scheer, U.; Dabauvalle, M.C., Localization of the Ran-GTP Binding Protein RanBP2 at the Cytoplasmic Side of the Nuclear Pore Complex. Eur J. Cell Biol. 1995, 68, 211-219.
166. Lin, D.H.; Zimmermann, S.; Stuwe, T.; Stuwe, E.; Hoelz, A., Structural and Functional Analysis of the C-Terminal Domain of NUP358/RanBP2. J. Mol. Biol. 2013, 425, 1318-1329.
167. Bichel, K.; Price, A.J.; Schaller, T.; Towers, G.J.; Freund, S.M.; James, L.C., HIV-1 Capsid Undergoes Coupled Binding and Isomerization by the Nuclear Pore Protein NUP358. Retrovirology 2013, 10, 81.
168. Yoo, S.; Myszka, D.G.; Yeh, C.; McMurray, M.; Hill, C.P.; Sundquist, W.I., Molecular Recognition in the HIV-1 Capsid/Cyclophilin A Complex. J. Mol. Biol. 1997, 269, 780-795.
169. Ferreira, P.A.; Nakayama, T.A.; Travis, G.H., Interconversion of Red Opsin Isoforms by the Cyclophilin-Related Chaperone Protein Ran-Binding Protein 2. Proc. Natl. Acad. Sci. U. S. A. 1997, 94, 1556-1561.
170. Mamede, J.I.; Sitbon, M.; Battini, J.L.; Courgnaud, V., Heterogeneous Susceptibility of Circulating SIV Isolate Capsids to HIV-Interacting Factors. Retrovirology 2013, 10, 77.
171. Yaseen, N.R.; Blobel, G., Two Distinct Classes of Ran-Binding Sites on the Nucleoporin Nup-358. Proc. Natl. Acad. Sci. U. S. A. 1999, 96, 5516-5521.
172. Higa, M.M.; Alam, S.L.; Sundquist, W.I.; Ullman, K.S., Molecular Characterization of the Ran-Binding Zinc Finger Domain of NUP153. J. Biol. Chem. 2007, 282, 17090-17100.
173. Prunuske, A.J.; Liu, J.; Elgort, S.; Joseph, J.; Dasso, M.; Ullman, K.S., Nuclear Envelope Breakdown Is Coordinated by Both NUP358/RanBP2 and NUP153, Two Nucleoporins with Zinc Finger Modules. Mol. Biol. Cell 2006, 17, 760-769.
174. Li, Y.; Kar, A.K.; Sodroski, J., Target Cell Type-Dependent Modulation of Human Immunodeficiency Virus Type 1 Capsid Disassembly by Cyclophilin A. J. Virol. 2009, 83, 10951-10962.
175. Keckesova, Z.; Ylinen, L.M.; Towers, G.J., Cyclophilin A Renders Human Immunodeficiency Virus Type 1 Sensitive to Old World Monkey but Not Human Trim5 Alpha Antiviral Activity. J. Virol. 2006, 80, 4683-4690.
176. Holman, A.G.; Coffin, J.M., Symmetrical Base Preferences Surrounding HIV-1, Avian Sarcoma/Leukosis Virus, and Murine Leukemia Virus Integration Sites. Proc. Natl. Acad. Sci. U. S. A. 2005, 102, 6103-6107.
177. Wu, X.; Li, Y.; Crise, B.; Burgess, S.M.; Munroe, D.J., Weak Palindromic Consensus Sequences Are a Common Feature Found at the Integration Target Sites of Many Retroviruses. J. Virol. 2005, 79, 5211-5214.
178. Pryciak, P.M.; Varmus, H.E., Nucleosomes, DNA-Binding Proteins, and DNA Sequence Modulate Retroviral Integration Target Site Selection. Cell 1992, 69, 769-780.
179. Wang, G.P.; Ciuffi, A.; Leipzig, J.; Berry, C.C.; Bushman, F.D., HIV Integration Site Selection: Analysis by Massively Parallel Pyrosequencing Reveals Association with Epigenetic Modifications. Genome Res. 2007, 17, 1186-1194.
180. Ciuffi, A.; Llano, M.; Poeschla, E.; Hoffmann, C.; Leipzig, J.; Shinn, P.; Ecker, J.R.; Bushman, F., A Role for LEDGF/p75 in Targeting HIV DNA Integration. Nat. Med. 2005, 11, 1287-1289.
181. Shun, M.C.; Raghavendra, N.K.; Vandegraaff, N.; Daigle, J.E.; Hughes, S.; Kellam, P.; Cherepanov, P.; Engelman, A., LEDGF/p75 Functions Downstream from Preintegration Complex Formation to Effect Gene-Specific HIV-1 Integration. Genes Dev. 2007, 21, 1767-1778.
182. Marshall, H.M.; Ronen, K.; Berry, C.; Llano, M.; Sutherland, H.; Saenz, D.; Bickmore, W.; Poeschla, E.; Bushman, F.D., Role of PSIP1/LEDGF/p75 in Lentiviral Infectivity and Integration Targeting. PLoS One 2007, 2, e1340.
183. Ocwieja, K.E.; Brady, T.L.; Ronen, K.; Huegel, A.; Roth, S.L.; Schaller, T.; James, L.C.; Towers, G.J.; Young, J.A.; Chanda, S.K., et al., HIV Integration Targeting: A Pathway Involving Transportin-3 and the Nuclear Pore Protein RanBP2. PLoS Pathog. 2011, 7, e1001313.
184. Koh, Y.; Wu, X.; Ferris, A.L.; Matreyek, K.A.; Smith, S.J.; Lee, K.; KewalRamani, V.N.; Hughes, S.H.; Engelman, A., Differential Effects of Human Immunodeficiency Virus Type 1 Capsid and Cellular Factors Nucleoporin 153 and LEDGF/p75 on the Efficiency and Specificity of Viral DNA Integration. J. Virol. 2013, 87, 648-658.
185. Vaquerizas, J.M.; Suyama, R.; Kind, J.; Miura, K.; Luscombe, N.M.; Akhtar, A., Nuclear Pore Proteins NUP153 and Megator Define Transcriptionally Active Regions in the Drosophila Genome. PLoS Genet. 2010, 6, e1000846.
186. Joseph, J.; Dasso, M., The Nucleoporin NUP358 Associates with and Regulates Interphase Microtubules. FEBS Lett. 2008, 582, 190-196.
187. Ambrose, Z.; Lee, K.; Ndjomou, J.; Xu, H.; Oztop, I.; Matous, J.; Takemura, T.; Unutmaz, D.; Engelman, A.; Hughes, S.H., et al., Human Immunodeficiency Virus Type 1 Capsid Mutation N74D Alters Cyclophilin A Dependence and Impairs Macrophage Infection. J. Virol. 2012, 86, 4708-4714.
188. Saini, M.; Potash, M.J., Novel Activities of Cyclophilin A and Cyclosporin A During HIV-1 Infection of Primary Lymphocytes and Macrophages. J. Immunol. 2006, 177, 443-449.
189. Goldstone, D.C.; Yap, M.W.; Robertson, L.E.; Haire, L.F.; Taylor, W.R.; Katzourakis, A.; Stoye, J.P.; Taylor, I.A., Structural and Functional Analysis of Prehistoric Lentiviruses Uncovers an Ancient Molecular Interface. Cell Host Microbe 2010, 8, 248-259.